Yahoo Web Search

Search results

    • Image courtesy of slidetodoc.com

      slidetodoc.com

      • GISTs are cancerous tumors that develop in the walls of your gastrointestinal tract in your digestive system. They’re a type of soft tissue sarcoma. Some gastrointestinal stromal tumors are small, about the size of a pencil eraser, and you might not notice them. But they can also grow large enough to cause symptoms and medical issues.
      my.clevelandclinic.org › health › diseases
  1. Apr 27, 2023 · For GISTs, the target of these drugs is an enzyme called tyrosine kinase that helps cancer cells grow. Targeted drug therapy for GISTs often begins with imatinib (Gleevec). Targeted drug treatments can be given: After surgery to lower the risk that the cancer will come back; Before surgery to shrink the tumor and make it easier to remove; As ...

  2. People also ask

  3. Jul 17, 2024 · A gastrointestinal stromal tumor is a type of sarcoma that develops in the connective tissue of the gastrointestinal tract. It’s often referred to as GIST. GISTs are usually found in adults between the ages of 30 and 50. Though rare, GISTs can also be found in children and young adults.

  4. Aug 24, 2023 · Gastrointestinal stromal tumor (GIST) is the most common malignant neoplasm of mesenchymal origin. GIST spans a wide clinical spectrum that ranges from tumors with essentially no metastatic potential to malignant and life-threatening spread diseases.

    • 10.1177/17588359231192388
    • 2023
  5. Aug 28, 2020 · Gastrointestinal stromal tumors (GIST) are usually found on the stomach or small intestine, but they can be found anywhere in or near the GI tract. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for gastrointestinal stromal tumors.

  6. Jun 8, 2022 · Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. GISTs mainly develop in older adults, and the median age of diagnosis is 60–65 years. The incidence of GISTs in young adult patients, defined as adults before 40, is less than 10%.

    • 10.3390/cancers14122831
    • 2022/06
    • Cancers (Basel). 2022 Jun; 14(12): 2831.
  7. Mar 2, 2021 · Recognizing the molecular pathogenesis of GIST has led to the introduction of targeted therapies, primarily the small-molecule tyrosine kinase inhibitor (TKI) imatinib into clinical practice, and this has been a revolutionary breakthrough in the treatment of patients with GIST, initially in metastatic disease [ 2, 3 ].

  8. Apr 11, 2023 · Most GISTs harbor characteristic mutations in KIT or platelet-derived growth factor receptor alpha (PDGFRA), while mutations in succinate dehydrogenase (SDH) or other genes are less frequent. The clinical presentation, diagnosis, and prognosis of GISTs will be discussed here.